I recall how there was endless debate about what the "2nd...

I recall how there was endless debate about what the "2nd Technology" was when it was announced earlier this year.   Apart from all the other clues we were given, I just noticed this interesting update in OBJ's "About OBJ’S technologies" text included in each company announcement :

Prior to the 3rd April Announcement "Licensing of Second Technology Negotiations" :
About OBJ’S technologies
...Complex 3-D array and moving magnetic fields have the ability to repulse certain molecules
to enhance diffusion and to alter the permeability of certain biological and non-biological
targets....

In and after the 3rd April Announcement "Licensing of Second Technology Negotiations" :
About OBJ’S technologies
...Complex 3-D magnetic fields produced by low cost microarrays or powdered
electromagnetic inductors have the ability to repulse certain molecules to enhance diffusion
and to alter the permeability of biological and non-biological targets....

Talk about Easter eggs.



And there is another notable difference :
Old :
...to offer a new way of managing the speed, depth of penetration and delivery of active ingredients in a wide range of pharmaceutical and consumer products.

New :
has already reached international markets to provide OBJ’s Partners with a new way of managing the speed, depth of penetration and delivery of active ingredients in a wide range of pharmaceutical, healthcare and consumer products.